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In recent decades, a cardiomyocyte membrane scaffolding protein bridging integrator 1 (BIN1) has emerged as a critical
multifunctional regulator of transverse-tubule (t-tubule) function and calcium signaling in cardiomyocytes. Encoded by a single
gene with 20 exons that are alternatively spliced, more than ten BIN1 protein isoforms are expressed with tissue and disease
specificity. The recently discovered cardiac alternatively spliced isoform BIN1 (cBIN1 or BIN1+13+17)plays a crucial role in
organizing membrane microfolds within cardiac t-tubules. These cBIN1-induced microfolds form functional dyad microdomains
by trafficking L-type calcium channels (LTCC) to t-tubule membrane and recruiting ryanodine receptors (RyR) to junctional
sarcoplasmic reticulum membrane. When cBIN1 is transcriptionally reduced as occurs in heart failure, cBIN1-microfolds are
disrupted and fail to form LTCC and RyR couplons. As a result, impaired dyad formation limits excitation-contraction coupling
thus cardiac contractility, and accumulation of orphaned leaky RyRs outside of dyads increases ventricular arrhythmias. Reduced
myocardial BIN1 in heart failure is also detectable at the blood level, and plasma BIN1 level predicts heart failure progression
and future arrhythmias in cardiomyopathy patients. Here we will review the recent progress in BIN1-related cardiomyocyte
biology studies and discuss the diagnostic and predictive values of cBIN1 in future clinical use.
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INTRODUCTION
Heart failure (HF), a common end-stage syndrome of differ-
ent cardiac diseases, affects millions of people worldwide
(Bui et al., 2011). Although there are significant advances
in its prevention, diagnosis, and treatment, effective early
diagnosis and therapy of HF are still largely limited and
its five-year morbidity and mortality remain high. Devel-
opment of new diagnostic and therapeutic tools requires
further understanding of molecular mechanisms underlying
*Corresponding author (email: TingTing.Hong@cshs.org)
HF progression. Normal cardiac contraction is initiated by
a sequence of calcium signaling events requiring specific
communication between L-type calcium channels (LTCC)
at the transverse-tubule (t-tubule) membrane and ryanodine
receptors (RyR) at the junctional sarcoplasmic reticulum
(jSR) membrane. At each heartbeat, initial action poten-
tial-induced calcium entry through activated LTCCs triggers
the subsequent massive calcium release from the SR store via
the calcium sensing and releasing RyRs, a process known as
calcium-induced-calcium-release (CICR). The synchrony of
CICR determines the strength of calcium transients and the
efficiency of excitation-contraction coupling (E-C coupling).
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A weakened calcium transient with E-C uncoupling is the
key pathophysiology of HF. Many membrane scaffolding
proteins including junctophilin 2 (JPH2), caveoline-3, and
the Bin/Amphiphysin/Rvs (BAR) domain-containing protein
bridging integrator 1 (BIN1, also known as amphiphysin 2)
(Ibrahim et al., 2011) have been described playing essential
roles in regulating E-C coupling. Of these, the cardiac iso-
form of BIN1, cBIN1 or BIN1+13+17,has been implicated
in the formation of t-tubule membrane microfolds to cluster
LTCCs and recruit phosphorylated RyRs for coupling with
LTCCs. As a result, functional LTCC-RyR couplons form
at these cBIN1-microdomains, controlling CICR and E-C
coupling. Furthermore, BIN1 is transcriptionally reduced in
failing hearts (Hong et al., 2012; Lyon et al., 2012), dimin-
ishing calcium transients and impairing cardiac contractility.
Here we will review the most recent understanding of how
BIN1 is coordinated to regulate the cardiac dyad system and
its potential usage for HF prediction and therapy develop-
ment.
BIN1 AND ITS DIFFERENT ISOFORMS
Four BAR protein-encoding genes have been identified
in the mammalian system, namely, Amphiphysin I, Bin1
(also known as AmpII), Bin2, and Bin3 (Lichte et al., 1992;
Sakamuro et al., 1996). All BAR genes encode protein prod-
ucts with a unique signature domain termed the BAR domain
(Sakamuro et al., 1996). As a member of the BAR-domain
containing protein superfamily, BIN1 contains a signature
N-terminal BAR-domain (N-BAR) encoded by exons 1–9.
The crystal structure of the N-BAR domain revealed a
dimeric interaction between helixes from each monomer to
form a 6-helix bundle in BIN1 dimers (Casal et al., 2006).
The structure of this dimer is similar to an elongated banana
shape (Peter et al., 2004; Fu and Hong, 2015). Thus, based
on the BAR domain shape of BIN1 and its general function
as a membrane curvature protein, BIN1 has been referred to
as the “banana” molecule (Qualmann et al., 2011). BIN1 has
been implicated in many cellular processes, such as inducing
membrane invagination (Frost et al., 2009) and initiating
tubulogenesis in skeletal muscle cells (Lee et al., 2002).
In human and mouse heart cells, BIN1 localizes to cardiac
t-tubules (Hong et al., 2010), forms t-tubule membrane
microdomains (Hong et al., 2014; Fu et al., 2016), facilitates
cytoskeleton-based calcium channel trafficking to t-tubule
membrane (Hong et al., 2010), and causes RyR movement
along the SR membrane (Fu et al., 2016).
Interestingly, these different cellular functions of BIN1
heavily rely on various BIN1 protein isoforms generated
from tissue specific alternative splicing of a single Bin1
gene with 20 exons (Figure 1). Over ten BIN1 protein
isoforms are encoded with tissue and disease specificity.
Using PCR detection of the cDNA fragments containing
the alternatively spliced region between exons 10 and 18 in
Bin1, we cloned four protein-encoding transcripts of Bin1
mRNA in adult mouse cardiomyocytes (Hong et al., 2014): a
small constitutive Bin1 (excluding exons 7, 11, and 13–17),
a constitutively alternatively spliced Bin1+17 (Bin1+exon
17), and two cardiac alternatively spliced variants Bin1+13
and Bin1+13+17 (cBIN1). A group of four exons 13–16 is
normally co-spliced together in neuronal cells to encode a
clathrin-binding domain, which targets neuronal BIN1 to
clathrin-coated pits to facilitate endocytosis (Taylor et al.,
2011) and neurotransmitter reuptake (Butler et al., 1997).
The skeletal spliced exon 11 encodes a phosphoinositide
binding domain that targets skeletal BIN1 to the plasma
membrane for biogenesis of skeletal t-tubules (Lee et al.,
2002). Although skeletal t-tubules have marked differences
from cardiac t-tubules in number, size and intracellular loca-
tion, with expression  of  the  skeletal  isoform BIN1+11+17,
Figure 1   (Color online) Alternative spliced Bin1 transcript variants in adult mouse tissues. N-BAR, N-Bin-amphiphysin-Rvs domain; PI, phosphoinositide
binding domain; CLAP, clathrin/AP2 binding region; MBD, myc binding domain; SH3, SH3 domain.
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analogous membrane microfolds may also exist within skele-
tal t-tubules. The most abundant BIN1 isoform in mouse
hearts is BIN1+13,which is known to be associated with cell
proliferation (Ge et al., 1999). On the other hand, cBIN1
(BIN1+13+17),the t-tubule localized cardiac isoform, pro-
motes N-WASP dependent actin polymerization and induces
actin-dependent densely packed t-tubule membrane micro-
folds (Hong et al., 2014). This particular cardiac isoform
cBIN1 is the only BIN1 isoform that is capable of rescuing
t-tubule microfolds in transgenic mice with conditional Bin1
knockout in cardiomyocytes (Hong et al., 2014). Further-
more, cBIN1 is the isoform organizing t-tubule LTCC-RyR
dyads (Fu et al., 2016). Detailed functions of other BIN1 iso-
forms in the heart await further studies.
THE ROLE OF BIN1 IN T-TUBULE
MICRODOMAIN ORGANIZATION AND
FUNCTION
In mammalian ventricular myocytes, t-tubules are well devel-
oped interconnected tubular membrane network with its pri-
mary transverse section regularly spaced in coincident with
the z-lines. The t-tubule system plays a significant role in
safeguarding the instantaneous excitation and synchronous
activation of nearly all calcium releasing channel RyRs at
the jSR membrane (Guo et al., 2013). It is well known that
LTCCs collect at t-tubule membrane to be in close physical
proximity to RyRs at the jSRmembrane, forming LTCC-RyR
dyads that facilitate CICR (Bers, 2002). Proper organization
of the two dyadic proteins LTCC and RyR at the membrane
microdomains is critical in maintaining normal cardiac cal-
cium signaling and heart contractility. In heart failure, dis-
organization in dyads impairs CICR and diminishes calcium
transients, limiting cardiac contractility.
BIN1 regulates dyad microdomain organization and func-
tion from four separate aspects (Figure 2, top panel). First,
BIN1 facilitates LTCC localization to t-tubule membrane.
LTCC forward trafficking to t-tubules follows “Targeted De-
livery” model of channel delivery, which was first introduced
for connexin 43 trafficking to cardiac intercalated discs
(Shaw et al., 2007). In “Targeted Delivery”, channel delivery
to a specific membrane subdomain requires the dynamic
microtubule highway and its coordination with channel itself
and a particular membrane anchor protein. In the case of
LTCC trafficking, LTCC-carrying microtubules are attracted
to BIN1 at t-tubule membrane (Hong et al., 2010). Once
tethered to BIN1, microtubules unload their cargo calcium
channels to BIN1 protein at the membrane. Thus, serving
as the membrane anchor protein for LTCCs, BIN1 causes
t-tubule concentration of the channel. Second, BIN1 also
facilitates the clustering of calcium channels that are already
at the t-tubule membrane. Super-resolution (10–20 nm)
fluorescent imaging revealed that LTCCs form large clusters
at BIN1-membrnae (Fu et al., 2016), which become smaller
in cardiomyocytes with heterozygous Bin1 deletion (Hong
et al., 2014; Fu and Hong, 2015). Channel clustering at
cBIN1-microdomains may also affect coupled-gating of
LTCCs therefore normal channel function. Third, in ad-
dition to trafficking and clustering LTCCs at the t-tubule
membrane, cBIN1 plays a critical role in recruiting the other
dyadic protein RyRs to the jSR membrane (Fu et al., 2016).
As a result, cBIN1 serves as a protein bridge important for
the formation and maintenance of LTCC-RyR couplons,
which are essential for normal E-C coupling. Recruitment
of RyRs to cBIN1 is phosphorylation dependent (Fu et al.,
2016). By recruiting S2808-phosphorylated RyRs with
increased calcium sensitivity and open probability (Marx
et al., 2000) to couple with LTCCs, cBIN1 increases CICR
gain necessary during an acute stress response in normal
hearts. Lastly, cBIN1 organizes the ultrastructure of t-tubule
membrane (Hong et al., 2014) supporting these channels.
This recently identified cardiac t-tubule membrane isoform
cBIN1 sculpts tiny microfolds at t-tubule membrane, which
not only house LTCC clusters but also create a “fuzzy space”
like extracellular ionic diffusion barrier (Hong et al., 2014).
With restricted diffusion of extracellular calcium ions within
the local microenvironment, cBIN1 controls the driving
force of LTCC currents. This protective ionic diffusion
barrier becomes even more significant during fast pacing
states where restricted diffusion can effectively limit a quick
depletion of extracellular calcium ions, preventing loss of
transmembrane ionic flux. When cBIN1 is reduced as occurs
in HF (Hong et al., 2012; Lyon et al., 2012; Caldwell et al.,
2014), not only channel localization to dyads is impaired, but
also removal of the diffusion barrier can deplete extracellular
ions, further diminishing LTCC current and impairing CICR
(Figure 2, bottom panel).
Whether functions of cBIN1-microdomains involve other
t-tubule scaffolding proteins including caveolin-3 and JPH2
remains unclear. Caveonlin-3 organized caveolae distributes
along t-tubules and caveolae distribution is altered in Bin1-
deleted mouse cardiomyocytes (Laury-Kleintop et al., 2015),
indicating crosstalk between cBIN1-microdomains and cave-
olae microdomains within t-tubules. JPH2 is a t-tubule/jSR
junctional protein and is involved in the maintenance of junc-
tional membrane structure, which when knocked down in-
creases the distance between t-tubule and jSR membrane and
disrupts jSR membrane complexes (van Oort et al., 2011; Wu
et al., 2012; Reynolds et al., 2013). A role of JPH2 in HF pro-
gression has been reported (see review in (Takeshima et al.,
2015)). Some studies indicate that JPH2 is down-regulated in
animal models of hypertrophic and dilated cardiomyopathy
(Zhang et al., 2013), and conditional knockdown of JPH2 in
the heart causes systolic heart failure in murine models (Chen
et al., 2013). Other studies report no significant changes of
JPH2 expression in failing hearts (Caldwell et al., 2014), or
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Figure 2   (Color online) Cartoon of cBIN1-microdomain regulated cardiac dyad function in healthy (top) and failing cardiomyocytes (bottom).
with recovery of heart function (Lyon et al., 2012). Whether
JPH2 can facilitate cBIN1-induced LTCC-RyR dyad forma-
tion is an interesting topic. Future studies will be necessary
to identify how these membrane microdomains interact with
each other at t-tubules to maintain a coordinated calcium sig-
naling event in healthy hearts and how normal interactions
are disrupted in HF.
It is also worth emphasizing that the dyad-organizing
cBIN1-microdomain is extremely dynamic, which re-
organizes within minutes of stress response (Fu et al.,
2016). Acute β-adrenergic receptor (β-AR) activation redis-
tributes cBIN1 to t-tubules, likely through accumulation of
BIN1-binding phospholipids (Lee et al., 2002), which are
known regulators of channel function (Fu et al., 2015). As
a result of cBIN1 redistribution, phosphorylated RyRs is
recruited to cBIN1-microdomains to couple with LTCCs at
the t-tubule membrane. Thus, cBIN1 controls β-AR-depen-
dent LTCC-RyR coupling at dyads during acute stress (Fu
et al., 2016), improving CICR gain and calcium transient
as observed previously (Zhou et al., 2009). When BIN1
is reduced, RyR recruitment into dyads will be impaired,
accumulation of uncoupled receptors outside of dyads not
only limits efficient CICR but also forms leaky receptor
clusters, impairing cardiac contractility (Hong et al., 2012)
and increasing arrhythmia risks (Hong et al., 2014). The
dynamic feature of cBIN1-microdomains suggests a possi-
ble membrane turnover from the microdomains, releasing
membrane and cBIN1 into circulation. As a result, cBIN1
is blood available and plasma cBIN1 is a potential indicator
for myocardial health (Hong et al., 2012). Future study
will be necessary to understand the molecular mechanisms
controlling the life cycles of cBIN1-microdomain, its re-
leasing mechanisms, and the biomarker potential of plasma
cBIN1. On the other hand, a similar skeletal BIN1-organized
membrane microdomain may also exist in skeletal t-tubules
to regulate LTCC and RyR function and contribute to skeletal
calcium signaling, which is important for skeletal muscle
health and disease (Zhou et al., 2016).
BIN1 IN HEART FAILURE PROGRESSION
As the fastest growing cardiovascular disorder affecting over
40million patients worldwide (Rosamond et al., 2007; Lloyd-
Jones et al., 2010; Roger et al., 2011), HF still awaits fur-
ther studies to understand its mechanistic progression. Such
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knowledge is in great need for effective development of new
diagnostic, prognostic, and therapeutic tools for HF, an end-
stage cardiac disease with poor clinical prognosis. The patho-
physiologic hallmark of HF is a weakened cardiac calcium
transient (Gómez et al., 1997; Litwin et al., 2000; Gómez
et al., 2001), which can be attributed to t-tubule remodeling
(Lyon et al., 2009; Louch et al., 2010; Wei et al., 2010) and
dyad uncoupling (Gómez et al., 1997; Gómez et al., 2001;
He et al., 2001; Louch et al., 2006; Bito et al., 2008; Louch
et al., 2010). T-tubule remodeling marks the transition from
hypertrophy to failure (Wei et al., 2010), contributing to the
progression of HF (see reviews in (Brette and Orchard, 2003;
Brette and Orchard, 2007; Louch et al., 2010; Ferrantini et
al., 2013; Guo et al., 2013; Ibrahim and Terracciano, 2013)).
Molecules like cBIN1 with the ability to modulate t-tubule
and dyad function are promising targets for future therapy de-
velopment. Given its roles in organizing t-tubule microfolds
and dyad microdomains, cBIN1 has emerged as a crucial
regulator of cardiac function in healthy and diseased hearts
(Hong et al., 2012; Laury-Kleintop et al., 2015).
The role of BIN1 in mechanistic HF progression was
first noted when constitutive Bin1 knockout mice died of
perinatal lethal cardiomyopathy (Muller et al., 2003). Later,
a decrease in BIN1 transcription was identified in acquired
human HF (Hong et al., 2012) and multiple animal models
of HF (Lyon et al., 2012; Caldwell et al., 2014), which
recovers during functional recovery (Lyon et al., 2012). In
failing cardiomyocytes, decreased BIN1 level impairs LTCC
trafficking (Hong et al., 2012; Lyon et al., 2012; Caldwell
et al., 2014), diminishing calcium transients. In zebrafish,
knockdown of Bin1 induces significant contractile dysfunc-
tion and cardiomyopathy (Hong et al., 2012). Mice with
cardiac conditional knockout of Bin1 gene developed dilated
cardiomyopathy when aged (starting at 8–10 months of age)
or with pressure overload (Laury-Kleintop et al., 2015).
Before decompensation into contractile dysfunction, young
adult mice (2–4 months of age) with Bin1 deletion already
have increased risks of ventricular arrhythmias. These data
indicate that in HF with reduced cBIN1 expression, disrup-
tion in cBIN1-microdomains not only impairs the dyadic
calcium releasing units, but also removes microfold-created
protective slow diffusion zone (Figure 2, bottom panel),
increasing susceptibility to ventricular arrhythmias (Hong et
al., 2014). Taken together, compromised cBIN1 contributes
a pivotal role in inducing both contractile pump failure and
electrical instability of failing hearts. Thus, cBIN1 based
microdomain is a potential therapeutic target for new HF
treatment. Future studies are necessary to identify whether
reduced Bin1 transcription or aberrant splicing of cardiac
exon 13 is responsible for cardiomyopathy development.
On the other hand, cBIN1 is a potential biomarker of
HF, which directly measures the biochemical health of car-
diomyocytes. Myocardial cBIN1 is released into circulation
possibly through a continuous turnover process of cBIN1-mi-
crodomain, providing a blood index of myocardial health
(Hong et al., 2012). In a cohort of arrhythmogenic right
ventricular cardiomyopathy patients, plasma BIN1 decreases
in patients with HF symptoms (Hong et al., 2012). Low
plasma levels of BIN1 correlates with HF status, and predicts
future arrhythmia incidences (Hong et al., 2012). A cardiac
specific blood test detecting the recently cloned functional
significant cBIN1 (Hong et al., 2014) is currently under
development, which when succeeded will greatly aid in the
diagnosis, prognosis and therapy guidance of HF patients.
CONCLUSIONS
As a multifunctional regulator of dyads at cardiac t-tubules,
BIN1 controls physiological calcium signaling in healthy car-
diomyocytes, and reduced BIN1 contributes to pathophysiol-
ogy of HF progression. Thus, understanding BIN1 biology in
normal and heart failure will have a great impact in disease
management and guided therapy. The identified cBIN1-mi-
crodomain may serve as a target for therapeutic development.
Understanding the mechanistic decrease of BIN1 in HF may
also help identify new pathways that can be targeted for new
therapy development. On the other hand, with its blood avail-
ability, plasma BIN1 carries a message of cardiac health and
serves as a potential biomarker of the biochemical health and
recovery potential of hearts. Developing a cardiac specific
cBIN1 assay, understanding the metabolic characteristics and
kinetics of BIN1 in human plasma, and learning other po-
tential confounding factors of plasma BIN1 are all necessary
steps to define a clinical test for risk stratification and therapy
guidance in millions of patients with acquired heart failure.
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